Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Adv Drug Deliv Rev. 2021 Sep 13;178:113971. doi: 10.1016/j.addr.2021.113971

Fig.2.

Fig.2.

Gelatin-MPs embedded in agarose scaffold. (A) Process diagram demonstrating the fabrication of scaffolds containing gelatin-MPs loaded with immunomodulatory signals. (B) Confocal microscopy image of gelatin-MPs (green) within an agarose scaffold. (C) Effect of the number density of gelatin-MPs on ovalbumin release, where ovalbumin is a model protein. All images/data in this figure reprinted with permission from S. Srinivasan, J.E. Babensee, Controlled Delivery of Immunomodulators from a Biomaterial Scaffold Niche to Induce a Tolerogenic Phenotype in Human Dendritic Cells, Acs Biomater Sci Eng. 6 (2020) 4062–4076. https://doi.org/10.1021/acsbiomaterials.0c00439. Copyright 2021. American Chemical Society.